Haemonetics | HAE - Assets


Haemonetics reported $2.4B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Avanos Medical USD 1.05B 23.6M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Cerus USD 221.86M 6.67M Dec/2025
Cooper Companies USD 12.48B 58.1M Mar/2026
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Globus Medical USD 5.44B 136.79M Mar/2026
Haemonetics USD 2.4B 94.96M Mar/2026
ICU Medical USD 4.01B 36.74M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
Masimo USD 1.64B 56.2M Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.72B 33.36M Mar/2026
Neogen USD 3.36B 953K Dec/2025
OraSure Technologies USD 379.17M 24M Mar/2026
Plus Therapeutics USD 19.92M 3.59M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
ResMed USD 8.78B 280.91M Mar/2026
STAAR Surgical USD 451.12M 560K Mar/2026
Steris USD 10.74B 145.8M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Surmodics USD 169.82M 8.74M Jun/2025
Teleflex USD 6.78B 164.24M Mar/2026
Terumo JPY 2.31T 55.3B Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
US Physical Therapy USD 1.24B 38.05M Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026